17:56 , Aug 29, 2018 |  BC Innovations  |  Distillery Techniques

Drug platforms; imaging

TECHNOLOGY: Structural analyses; other An electron microscopy-based method for identifying epitopes that elicit potent neutralizing antibodies could be used to guide the development of vaccines for infectious diseases. The method involves six steps: digesting animal-...
07:00 , Mar 27, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Hematology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Hematology Thrombocytopenia Growth hormone 1 (GH1); thrombopoietin receptor (CD110; MPL) In vitro and mouse studies suggest combined stimulation of MPL and GH1 could help treat thrombocytopenia....
08:00 , Dec 24, 2007 |  BC Week In Review  |  Company News

Bioton, The Medical House plc deal

Bioton's BioPartners GmbH subsidiary ended a 2005 deal under which MLH supplied its GH1 needle-free delivery system for BioPartners' Valtropin somatropin (see BioCentury, Feb. 28, 2005). BioPartners said MLH was unable to supply GH1 for...
08:00 , Feb 28, 2005 |  BC Week In Review  |  Company News

BioPartners, The Medical House plc deal

The companies signed a 10-year worldwide licensing and supply agreement for MLH's GH1 needle-free delivery system to deliver BioPartners' Valtropin somatropin recombinant human growth hormone (hGH). Valtropin was developed with LG Life Sciences (Seoul, South...
08:00 , Nov 25, 2002 |  BioCentury  |  Tools & Techniques

Chronic biologics

Chronic biologics Company Product Dosing Mol wt (kD) Amgen Aranesp darbepoetin alfa 1 SC/week 33.5 Amgen Epogen epoetin alfa 3 SC/week 30.4 Amgen Kineret anakinra 1 SC/day 17.3 Amgen/Wyeth Enbrel etanercept 2 SC/week 150.0 Biogen...